Is DOTS-Plus a Feasible and Cost-Effective Strategy?

Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.

Detalles Bibliográficos
Autores principales: Garner, Paul, Alejandria, Marissa, Lansang, Mary Ann
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564173/
https://www.ncbi.nlm.nih.gov/pubmed/16968122
http://dx.doi.org/10.1371/journal.pmed.0030350
_version_ 1782129553730174976
author Garner, Paul
Alejandria, Marissa
Lansang, Mary Ann
author_facet Garner, Paul
Alejandria, Marissa
Lansang, Mary Ann
author_sort Garner, Paul
collection PubMed
description Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.
format Text
id pubmed-1564173
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-15641732006-09-20 Is DOTS-Plus a Feasible and Cost-Effective Strategy? Garner, Paul Alejandria, Marissa Lansang, Mary Ann PLoS Med Perspectives Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines. Public Library of Science 2006-09 2006-09-12 /pmc/articles/PMC1564173/ /pubmed/16968122 http://dx.doi.org/10.1371/journal.pmed.0030350 Text en © 2006 Garner et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Perspectives
Garner, Paul
Alejandria, Marissa
Lansang, Mary Ann
Is DOTS-Plus a Feasible and Cost-Effective Strategy?
title Is DOTS-Plus a Feasible and Cost-Effective Strategy?
title_full Is DOTS-Plus a Feasible and Cost-Effective Strategy?
title_fullStr Is DOTS-Plus a Feasible and Cost-Effective Strategy?
title_full_unstemmed Is DOTS-Plus a Feasible and Cost-Effective Strategy?
title_short Is DOTS-Plus a Feasible and Cost-Effective Strategy?
title_sort is dots-plus a feasible and cost-effective strategy?
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564173/
https://www.ncbi.nlm.nih.gov/pubmed/16968122
http://dx.doi.org/10.1371/journal.pmed.0030350
work_keys_str_mv AT garnerpaul isdotsplusafeasibleandcosteffectivestrategy
AT alejandriamarissa isdotsplusafeasibleandcosteffectivestrategy
AT lansangmaryann isdotsplusafeasibleandcosteffectivestrategy

Ejemplares similares